TITLE

Spironolactone

PUB. DATE
March 2007
SOURCE
Reactions Weekly;3/10/2007, Issue 1142, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a case report of a man with congestive heart failure and was receiving spironolactone daily. It states that a condition called gynecomastia which is an increasing breast size in the patient during his treatment made his medication replaced by eplerenone. The author mentions that spironolactone causes increased metabolic clearance of testosterone and higher estradiol production.
ACCESSION #
24885699

 

Related Articles

  • Spironolactone.  // Reactions Weekly;7/14/2007, Issue 1160, p28 

    The article describes the case of a 76-year-old man who had Parkinson's disease with stable motor function and congestive heart failure (CHF). As a result of worsening CHF, he was given spironolactone. A week after treatment, he experienced abrupt motor deterioration. The drug was discontinued...

  • Older heart drug cuts death rate by 30%. Hensley, Scott // Modern Healthcare;07/26/99, Vol. 29 Issue 30, p24 

    Discusses the re-discovery of spironolactone, a drug that blocks the action of a hormone called aldosterone. Implications of the discovery of the drug on hospitals and health systems; Number of people hospitalized with congestive heart failure.

  • Old drug, new treatment for severe CHF.  // Brown University Long-Term Care Quality Advisor;Oct99, Vol. 11 Issue 10, p1 

    Reports that generic drug spironolactone has proved to be effective in treating life-threatening congestive heart failure, reducing the death rate by 30 percent. INSET: Aging heads need social support too.

  • Male Gynecomastia. Haynes, Bridgett A.; Mookadam, Farouk // Mayo Clinic Proceedings;Aug2009, Vol. 84 Issue 8, p672 

    The article presents a case study of a 62-year-old man with known coronary artery disease and ischemic left ventricular dysfunction, and with severe gynecomastia. The patient had been under medication of spironolactone daily for eight years as part of his regimen for congestive heart failure. It...

  • Aldactone instead of potassium. P.F.C. // Cortlandt Forum;03/25/97, Vol. 10 Issue 3, p91 

    Advises doctors who are treating patients in congestive heart failure to prescribe concomitant spironolactone, rather than potassium supplements. Patients' complaints about potassium supplements.

  • Aldosterone Receptor Antagonists for Hypertension: What Do They Offer? Liew, Danny; Krum, Henry // Drugs;2003, Vol. 63 Issue 19, p1963 

    Aldosterone is an important and independent target for therapeutic intervention in hypertension and hypertension-related diseases. Its actions, once thought to be limited to the distal convoluted tubule of the kidney, are now recognised to be wide-ranging, including interactions with...

  • 242 The addition of spironolactone to standard therapy in congestive heart failure: how predicts the response. Feola, M.; Vado, A.; Menardi, E.; Visconti, G.; Deorsola, A.; Milanese, U.; Uslenghi, E. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p49 

    An abstract of the article "The Addition of Spironolactone to Standard Therapy in Congestive Heart Failure: How Predicts the Response," by M. Feola and colleagues is presented.

  • 795 Clinical, hemodynamic, antiarrythmic and neurohumoral effects of high everyday spironolactone doses in treatment severe congestive heart failure patients. Skvortsov, A.; Mareyev, V.; Chelmakina, S.; Baklanova, N.; Belenkov, Y.U. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p173 

    An abstract of the study "Clinical, hemodynamic, antiarrythmic and neurohumoral effects of high everyday spironolactone doses in treatment severe congestive heart failure patients," by A. Skvortsov et al. is presented.

  • Blocking aldosterone can reduce mortality in severe heart failure.  // Geriatrics;Jan99, Vol. 54 Issue 1, p60 

    Shows that adding spironolactone to standard therapy for severe congestive heart failure has life-saving benefits. Comments from Doctor Bertram Pitt; Results from a double-blind study; Background information on spironolactone.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics